{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:58:28Z","timestamp":1785355108673,"version":"3.55.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,7]]},"abstract":"<jats:p>CXC motif chemokine receptor type 4 (CXCR4) has an association with normal and abnormal progression. Previous studies have demonstrated the involvement of CXCR4 in breast cancer (BC), particularly in promoting metastatic progression. However, most of the existing evidence originates from basic research. Our study aims to evaluate novel the expression profiles of CXCR4 in BC. Computerized literature search was done on the online accessible databases, including ONCOMINE, Kaplan\u2013Meier plotter, TCGA database and Breast Cancer Gene-Expression Miner v4.3 to explore the expression profile and prognostic roles of CXCR4. CXCR4 overexpression was associated with BC versus normal control. Elevated CXCR4 expression predicted better PFS, but no survival rate benefit in BC patients. Moreover, there is a survival rate benefit with high expression of CXCR4 mRNA in the negative ER but the positive ER group. CXCR4 was more frequently overexpressed in BC patients with negative expression of ER and PR and negative expression of HER-2. For molecular subtypes analysis, higher expression of CXCR4 was associated with Basal-like and HER-2 subtypes than luminal A and luminal B subtypes. Moreover, we demonstrate a positive correlation between high expression of CXCR4 and low expression of LASP1 and EIF4A1 via gene correlation targeted analysis, which is consistent with the result among the triple-negative breast cancer patients. Our results suggest that CXCR4 can be used as a biological factor to predict the prognosis of BC patients, especially those with triple-negative breast cancer, and is also a tumor marker with potential value in the future treatment of BC.<\/jats:p>","DOI":"10.1097\/md.0000000000045356","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:01:30Z","timestamp":1762538490000},"page":"e45356","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["CXCR4 expression serves as a promising candidate target in the treatment of breast cancer"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5874-3309","authenticated-orcid":false,"given":"Fengqing","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People\u2019s Republic of China"},{"name":"Youjiang Medical University For Nationalities, Baise, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People\u2019s Republic of China"},{"name":"Youjiang Medical University For Nationalities, Baise, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6854-2194","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Affiliated Hospital of Jiujiang University, Jiujiang, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic.","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"R2-20260729","first-page":"7","article-title":"Cancer statistics, 2018.","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/ijms22010173","article-title":"PI3K\/AKT\/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects.","volume":"22","author":"Miricescu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R4-20260729","first-page":"1","article-title":"A review of prognostic and predictive biomarkers in breast cancer.","volume":"23","author":"Tarighati","year":"2023","journal-title":"Clin Exp Med"},{"key":"R5-20260729","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.3390\/cancers14215444","article-title":"Classic and new markers in diagnostics and classification of breast cancer.","volume":"14","author":"Be\u0148a\u010dka","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R6-20260729","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s12885-015-1569-2","article-title":"Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.","volume":"15","author":"Hong","year":"2015","journal-title":"BMC Cancer"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"1035402","DOI":"10.3389\/fimmu.2022.1035402","article-title":"Autoantibodies as biomarkers for breast cancer diagnosis and prognosis.","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"R8-20260729","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.yexmp.2019.04.003","article-title":"Concise approach for screening long non-coding RNAs functionally linked to human breast cancer associated genes.","volume":"108","author":"Shin","year":"2019","journal-title":"Exp Mol Pathol"},{"key":"R9-20260729","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1634\/theoncologist.2018-0697","article-title":"Incorporating MicroRNA into molecular phenotypes of circulating tumor cells enhances the prognostic accuracy for patients with metastatic breast cancer.","volume":"24","author":"Tan","year":"2019","journal-title":"Oncologist"},{"key":"R10-20260729","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cyto.2018.02.010","article-title":"Chemokines in breast cancer: regulating metabolism.","volume":"109","author":"Gao","year":"2018","journal-title":"Cytokine"},{"key":"R11-20260729","first-page":"60","article-title":"Upregulation of C-X-C chemokine receptor type 4 (CXCR4) in the breast cancer stem like cells.","volume":"12","author":"Kamalabadi-Farahani","year":"2023","journal-title":"Am J Stem Cells"},{"key":"R12-20260729","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/ijc.34457","article-title":"Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.","volume":"152","author":"Klusa","year":"2023","journal-title":"Int J Cancer"},{"key":"R13-20260729","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/cancers15041021","article-title":"Inhibition of CXCR4 enhances the efficacy of radiotherapy in metastatic prostate cancer models.","volume":"15","author":"Gupta","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R14-20260729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-022-01695-6","article-title":"MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4\/FOXM1\/RRM2 axis.","volume":"22","author":"Khan","year":"2023","journal-title":"Mol Cancer"},{"key":"R15-20260729","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1007\/s11033-023-08479-1","article-title":"Involvement of CXCL12\/CXCR4 axis in colorectal cancer: a mini-review.","volume":"50","author":"Bocchi","year":"2023","journal-title":"Mol Biol Rep"},{"key":"R16-20260729","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10549-015-3463-7","article-title":"Inhibition of SDF-1\/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.","volume":"152","author":"Gr\u00fcndker","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R17-20260729","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.","volume":"9","author":"Rhodes","year":"2007","journal-title":"Neoplasia"},{"key":"R18-20260729","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.","volume":"123","author":"Gy\u00f6rffy","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"R19-20260729","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses.","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"R20-20260729","doi-asserted-by":"crossref","first-page":"bas060","DOI":"10.1093\/database\/bas060","article-title":"bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.","volume":"2013","author":"J\u00e9z\u00e9quel","year":"2013","journal-title":"Database (Oxford)"},{"key":"R21-20260729","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10549-011-1457-7","article-title":"bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.","volume":"131","author":"J\u00e9z\u00e9quel","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R22-20260729","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12149-018-1290-8","article-title":"CXCR4-directed theranostics in oncology and inflammation.","volume":"32","author":"Kircher","year":"2018","journal-title":"Ann Nucl Med"},{"issue":"Pt 2","key":"R23-20260729","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.semcancer.2022.03.019","article-title":"Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression.","volume":"86","author":"Alsayed","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R24-20260729","doi-asserted-by":"crossref","first-page":"188790","DOI":"10.1016\/j.bbcan.2022.188790","article-title":"Demystifying the CXCR4 conundrum in cancer biology: beyond the surface signaling paradigm.","volume":"1877","author":"Nengroo","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R25-20260729","first-page":"680","article-title":"Breast cancer survival analysis based on immunohistochemistry subtypes (ER\/PR\/HER2): a retrospective cohort study.","volume":"19","author":"Poorolajal","year":"2016","journal-title":"Arch Iran Med"},{"key":"R26-20260729","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"R27-20260729","doi-asserted-by":"crossref","first-page":"e71864","DOI":"10.1371\/journal.pone.0071864","article-title":"Upregulated expression of C-x-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"R28-20260729","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2005.06.021","article-title":"Functions of CXCL12 and CXCR4 in breast cancer.","volume":"238","author":"Luker","year":"2006","journal-title":"Cancer Lett"},{"key":"R29-20260729","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3390\/jcm12041524","article-title":"Current treatment landscape for early triple-negative breast cancer (TNBC).","volume":"12","author":"Lee","year":"2023","journal-title":"J Clin Med"},{"key":"R30-20260729","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3390\/cancers15092661","article-title":"Endorsement of TNBC biomarkers in precision therapy by nanotechnology.","volume":"15","author":"Chaudhuri","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R31-20260729","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/21623945.2022.2069311","article-title":"Identification of FOXM1 and CXCR4 as key genes in breast cancer prevention and prognosis after intermittent energy restriction through bioinformatics and functional analyses.","volume":"11","author":"Li","year":"2022","journal-title":"Adipocyte"},{"key":"R32-20260729","doi-asserted-by":"crossref","first-page":"116335","DOI":"10.1016\/j.envres.2023.116335","article-title":"CXCR4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12\/CXCR4 signaling axis in preclinical breast cancer model.","volume":"232","author":"Gupta","year":"2023","journal-title":"Environ Res"},{"key":"R33-20260729","doi-asserted-by":"crossref","first-page":"156344","DOI":"10.1016\/j.cyto.2023.156344","article-title":"Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: a breast cancer and glioblastoma view.","volume":"170","author":"Gon\u00e7alves","year":"2023","journal-title":"Cytokine"},{"key":"R34-20260729","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fonc.2019.00284","article-title":"The CXCR4-LASP1-eIF4F axis promotes translation of oncogenic proteins in triple-negative breast cancer cells.","volume":"9","author":"Howard","year":"2019","journal-title":"Front Oncol"},{"key":"R35-20260729","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","article-title":"The plasticity of mRNA translation during cancer progression and therapy resistance.","volume":"21","author":"Fabbri","year":"2021","journal-title":"Nat Rev Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:02:03Z","timestamp":1785351723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":35,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045356","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"2024-04-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}